Диагностика и дифференциальная диагностика идиопатических воспалительных демиелинизирующих заболеваний центральной нервной системы
Диссертация
I стадия отражает компенсацию неврологического дефицита с функциональной реорганизацией моторных зон коры, соответствует рецндивирующе-ремнттнрующему рассеянному склерозу с обратимым нарушением неврологических функций и характеризуется относительным снижением метаболизма глюкозы преимущественно в лобной и теменной долях доминантного полушарияII стадия отражает истощение компенсации… Читать ещё >
Список литературы
- Алекберова З.С., Решетник Т. М., Родене ка-Ло по вох СГ. с соавт. Васкулопатия у бальных систем кой крас ной волчанкой с антнфосфолнпндным синдромом.//Тер. Архив,-1995−5.-с41−44,
- Балу да М.В., Тлеп туков И. К, АнтнфосфояипндныЙ синдром -эндогенный фактор риска возникновения тромбозов.// Тромбоз, гемостаз и реология.-2000,-4,-с24−29.
- Барбас ИМ, Скоромед А. А. Рассеянный склероз: опыт лечения и профилактика обострений СГ16.-2003.-124 с.
- Баркаган З.С. Клкннко-патоготсгнческне варианты, номенклатура и основы диагностики гематогенных тромбофнлкй, // Проблемы гематод,-199б,-3,-с5−15
- Ьисага Г. Н. Легкие цепи иммуноглобулинов цереброспинальной жидкости прн определении активности патологического процесса.// В кн.: Головкин В. И. Калинина Н. М (Ред.) Иммуноопосрелованный ремитирующий рассеянный склероз. СПб.-2003,-с, 51−64.
- Бркнар В, В. Позер Ч. М. Лабораторные методы в диагностике рассеянного склероза. И Журнал неврологни и психиатрии им. С. С. Корсакова.-2002,-№ 1 (специальный выпуск).-с.7−14.
- Ганнушкнна И.В. Коллатеральное кровообращение в мозге. М&bdquo- Медицина.-1973.-256 с.
- Ганну1нкииа И.В., Шафранова ВН., Рясина Т. В. Функциональная ангноархнтектоника головного мозга. М., Медицина, — ?977.-240 с,
- Грннштейн ЮН Васкулиты, Красноярск, ИПК Платина.-2СХ)1 .-169 с.
- Грязева И В,. Климович В. Б., Пашкова С. Ф. Моноклональные антитела к легким цепям иммуноглобулинов человека и их применение в иммуноанализе. // Иммунология.-1994.-№ 3.-с.31−37.
- Гуеев Е.И., Бойко А.Н, Рассеянный склероз: от изучения нммунопатогенеза к новым методам лечения. М., 2001.-128 с.
- Гусев Е.и., Демина t.j1, Бойко А. Н. Рассеянный склероз, М,-1997.-4бЗс
- Дууе П. Топический диагноз в неврологии. Н Москва. ¦ 1997.
- Ельчанинов А.П. Тромбофилнчеекнй фактор и пути его избирательной коррекции при ранней днецнркуляторной энцефалопатии. СПб.-2004.-64с.
- Ельчанинов АЛ., Капустин С.И, Генетические и приобретенные дегермнналш днецнркуляторной энцефалопатии в молодом возрасте, // Тромбоз, гемостаз и рсологня.-2002.-Т.2.-№ 10.- С.50−54.
- Ельчанинов А.П., Капустин С-И" Сиротки на О.В. с соавт, Генетические полиморфизмы н волчаночный антикоагулянт как факторы риска днецнркуляторной энцефалопатии в молодом возрасте. //Жури. Нсврол. и психиатр, (спец, выпуск «Инсульт»).-2002.-№ 5.- С.37−42.
- Ельчанинов А.П., Капустин С. И. Генетические и приобретенные детерминанты днецнркуляторной энцефалопатии в молодом возрасте. И Тромбоз, гемостаз и реология,-2002-Т.2, — № 10.- С.50−54.
- Завалншин И. А. Рассеянный склероз и боковой амиотрофический склероз: развитие представлений об этнологии и патогенезе. // Ж. невропатол. и психиатрии им. С. С. Корсакова, 1996.-ХгГ-С.24−28.
- Зинченко А. П, Рассеянный склероз и энисфаломи сл нт-Л. 1973.-296 с.
- Зыби на Н.Н., Бнсага Г. Н., Фролова М. Ю, «Окисл ительный стресс» при рассеянном склерозе. Ц В кн: Головкин В. И., Калинина Н. М, (Ред.) Иммуноопосредованный ремитирующий рассеянный склероз, СПб, 2003,-CI01−125.
- Иммуноопосредовшный ремитирующий рассеянный склероз. Ред.: Головкин В Н., Калинина Н. М., СП6.-2003.-200 с.
- Калашникова АЛ. Специфические лабораторные маркеры демнелиннзирующего процесса. Н В кн.: Головкин В, И., Калинина Н. М. (Ред.) Иммуноапосредованный ремитирующий рассеянный склероз. СП6.-2003.-С. 81−87.
- Калашникова Л.А. Нарушения мозгового кровообращения н другие неврологические проявления антнфосфолнпилного синдрома. // Жури, Неврал, н психиатр., .997.-10.-с65−73.
- Крыжановскнй Г. Н. / Введение в патофизиологию. U Москва, изд-ао РГМУ.- 2000.-71 е.
- Крыжановскнй ГЛ. Общая патофизиология нервной системы, М, Медицина, 1997.
- Лещин екая Е.В., Паннлова Е. И., Маргыиенко И. Н. Хронический некротический энцефалит у детей. // Архив патологии -1983,-Хг4.-с.20−24
- Лобзин Ю, В. Усков А. Н-. Козлов С-С. Лайм-боррелиоз (нксодовые клещевые боррелнозы), СПб, «Фолиант"-.-000 г. .-174 е.
- Марков Д А., Леоновнч А, Л. Рассеян ный склероз. М--1976.-276с.
- Насонов ЕЛ., Алекберова З. С., Калашников-! Л.А, с соавт. Антифоефолнпндный синдром (синдром Hughes) — J0 лет изучения в России. // Клнн, Медицина.-1998.-2- 4−11.
- Панов AJ, Зннченко АЛ, Диагностика рассеянного склероза и энцефаломиелита. М. 1970.-270 с.
- Паншина A.M. Тромбофнлия, обусловленная полиморфизмом интегрнновых рецепторов тромбоцитов, // Тромбоз, гемостаз н реология. ¦ 2001-Т2-№ 8.-с 13−20.
- Петрищев Н-Н-1 Власов Т. Д. Физиология и патология эндотелия. В кн.: Дисфункция эндотелия. Причины, механизмы, фармакологическая коррекция. Под ред. Hi (Петрищева, C I 16. изд-во СПбГМУ ,-2003,-с.4−38.
- Поздняков A3- Протонная магнитно-резонансная спектрография головного мозга в диагностике ремиссии и зкзацербаини заболевания, // В кн.: Иммуноолосрсдованный ремитирующий рассеянный склероз, под ред Головкина В. И» Калининой Н. М. СП6.-2003.-С-35−50.
- Поздняков А, В" Тютнн Л. А., Б н сага Г. Н., Олннлк М. М. Протонная магнитно-резонансная спектроскопия при ремитирующем и вторнчно-прогрессируюшем рассеянном склерозе. // Журнал неврологии и психиатрии. 200I. — № 4, — с, 36−39,
- Прахова J1.H. Изменения скорости метаболизма глюкозы в головном мозге при рассеянном склерозе и нх роль в формировании клинической картины заболевания И Автореферат лисе... .к м.и. СПб.-2003.-21с.
- Протас ИЛ Герпетический энцефалит: клиника, патогенез, терапия. Мннск.-2<�Ю0.-175 с.
- Протас ИЛ, Недзьведь М, К" Коломиеи А. Г, с соавт Особенности клиники и течения хронического герпетического энцефалита у детей, Н Педиатрия,-1997, — № 2.-с.6 3−65,
- Решетняк Т.М. Антифосфолнпидный синдром: диагноз и принципы терапии, Н Consilium medicum. 2002.-Т, 4.-№ 8.
- Скрипченко Н.В., Иванова Г, П., Трофимова Т. Н. Моргаикий Н.В. Особенности клещевого 'Энцефалита у детей. Н Инфекционные болезни, 2004.-T2.-.Nt3,-c, 5−10,
- Скриггчснко Н.В., Стерши нов Я.Ю" Трофимова Т. Н. с соавт. Диссеминнрованные энцефаломнелнты у детей: диагностика, клиника, лечение, диспансеризация. Метод, рекомендации, СПб, 2004,-60с,
- Сорокина МЛ, Скрипченко Н, В. Вирусные энцефалиты и мснннгоэнцсфалнты у детей. М. «Медицина» 2004,-416с.
- Спнрнн П.Н., Пизова Н. В., Степанов И. О. Аигнфосфолнпидный синдром и рассеянный склерон дифференциально-диагностические аспекты, Н Журн.нсвроло! ни и психиатрии нм. С'.С Корсакоыа, 2002-специальный выпуск -.-.42−45.
- Старшиной Я.Ю., Скрипченко Н. В. Жслезннкова Г. Ф. с соавт. Диссемннированные энцефаломиелиты у детей: клиннко-иммунологичсскис н томографические корреляции. // Детские инфекции, 2003.-№ 2- С.9−13.
- Столяров И.Д., Осетров Б. А. Рассеянный склероз, СПб., 2002,-175с.
- Тодуа Ф.И. Окуджава М, В, Лачкепнанн А.Н. Основные различия МРТ-картины при первично и вторично хронически прогрессирующих формах рассеянного склероза. И Неврол. Журнал.-1 999.-Т4 .-№ 2: 26−29.
- Тотолян А.А., Балдуева И.А, Бубнова Л. И. с соавт. Стандартизация методов иммунофенотнлирования клеток крови н костного мозш человека. // Медицинская иммунология.-1999.-т. 1, № 5.-с.21−43.
- Тотолян Н.А. Клииико-нммунологнческне сопоставления у больных рассеянным склерозом. Днсс., к.м.н" Санкт-Петербург, 1993, 185с,
- ТринитатскнЙ Ю-В. Магнитно-резонансная томография с контрастным усилением как показатель активности демнелинизирующего процесса при рассеянном склерозе. // Материалы 10-й научно-практической конференции «Ненронммуншогня» СПб. — 2001. — с. 268−270,
- Трофимова Т.Н. Лучевая диагностика нейроепида. // Нейрохирургия и неврология детского возраста,-2002.-Ха1 .-с.28−33.
- Флетчер Р, Флетчер С, Вагнер Э. Клиническая эпидемиология: основы доказательной медицины. МЛ998.-345 с,
- Холи и А.В. Магнитно-резонансная томография при заболеваниях центральной нервной системы. СПб, «Г иппократ», 1999,
- Хондкарнан О.А., Завалншнн И, А" Невская 0, М. Рассеянный склероз, М. 1987,
- Шмелева В. М, Гмпергомоцнстеи11 емня и тромбоз, // Тромбоз, гемостаз и реологня.-2000.-4 (4).-с2б-29.
- Шмидт Е.В., Лунев O.K., Верещагин Н.В, Сосудистые заболевания головного и елннного мозга. М. Медицина, 1976,
- Шмндт TJL, Яхно Н. Н. Рассеянный склероз. М. «Медицина». -2003, — 160с.
- Шмыреа ВН., Мартынов Л И, Гулеаская Т.С. с соавт. Поражение белого вещества головного мозга (лсЙкоареоз): частота, факгоры риска, патогенез, клиническая значимость. Неврологический журнал.-2000. е.47−54,
- Шульга А.И. Неврологическая, висцеральная симптоматика и лечение рассеянного склероза. Дисс.. .д.м.н., Киев. 1973.
- Энциклопедический словарь медицинских терминов, М. 1982- Т, 2, с, 241,
- Abele-Horn М, Franck W., Busch U. et al. Transverse myelitis associated with mycoplasma pneumoniae infection,//CHn. Infect. Dis. 1997.-26,-р909−912.
- Aboul-Enein F" Rauschka H., Kornek B. ei al. Preferential loss of myeltn-assoriated glycoprotein reflects hypoxia-1 ike white matter damage in stroke and inflammatory brain diseases. // J, of Neuropathol. And Experim. Neurol. 2003.-62.p25−33,
- Adams C.W.M., Abdulta Y. H-, Torres E.M., Poston R. N, Periventricular lesions in multiple sclerosis- their perivenous origin and relationship to granular cpcndymilis. // Neuropathol. & Applied Ncurobiol. l987,-l3,-pI41−152,
- Akhyani N." Bcrti R. Вгеппал M il. et al. Tissue distribution and variant characterization of human herpesvirus (HHV)-6: increased prevalence of HHV-6A in patients with multiple sclerosis. J. H Infect. Dis. 2000.- 182.-pl321−1325.
- Albucher J., Lauque D, Geyer I. el al. Transverse myelitis caused by mycoplasma pneumoniae infection. Rev. // Neurol. (Paris) 1995--15l.-p350353.
- Allen E.V., McQuaid S., Mirakhur M-. Ncvin G. Pathological abnormalities in (he normal-appearing while mailer in multiple sclerosis, // Neurol. Sci 2001.-22,-pl41-l44.
- Amber IJ-. Hihbs Jr. J.В. Taintor R.R., Vavrin Z- The L-arginin dependent effector mechanism is induced in in murine adenocarcinoma cells by culture supernatant from cytotoxic activated macrophages. Ц J. Leucoc. Biol. 1988.-43 (2),-pl87-l92,
- Andersen 0. Myelitis. // Current Opinion in Neurol. 2000.-13.-p3l 1−316.
- Anderson M J. Parvoviruses as agents of human disease. It Prog, Med, Virol, 1987.-34.-p55−69.
- Andersson M., Alvarez-Cermeno J. Bernardi J. el al. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. // J. Neurol. Netirosurg. Psychiatry 1994.-57.-p897−902.
- Apak R.A. Kose G., Aula г B. ct a I. Acute disseminated encephalitis in childhood: report of 10cases. //J. Child. Neurol. 1999.-14-pi98−201,
- Archelos J.J., Hartung H.P. Adhesion molecules in multiple sclerosis: a review. // In: Frontiers in Multiple Sclerosis, V.2. Eds, — Siva A., Kcssclring J., Thompson AJ. Martin Dunitz, l999.-S5.-pI 16.
- Ashcrson R. A, Ccrvcra R, In- Kelley W.N. (Ed.) Antiphospholipid syndrome. Textbook of Rheumatology. Philadelphia, 1997.-pl057-l064.
- Batfour НД, Schiff G.M., Bloom J.E. Encephalitis associated with erythema infectiosum. // IPediatr.- 1970.-77.-pl33−136,
- Balo j.A. Encephalitis periaxialis conccntrica. !i Arch. Neurol. 1928,-l9.-p242−264.
- Balo J. A, Leukocnkephalitis periaxialis conccntricarol. // Maguar Orv. Arch. l927.-28,-pl08-l24,
- Barkhof F, Spinal cord changes in multiple sclerosis and differential diagnosis. II 20lh Congress of the ECTRIMS- teaching course.-Austria, Vienna, 6−9 0cl, 2004,
- Barkhof F. The role of magnetic resonanc imaging in diagnosis of mulliplc sclerosis. // In: Multiple Sclerosis: Clinical challenges and controversies, Eds.: Thompson A.J., Polman C, Hohlfeld R. Martin Dunitz, 1997,43−64.
- Barkhof F., Filippi M" Miller D.H. el al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. // Brain 1997.-v.l20-p2059−2069,
- Barkovich AJ. Pediatric Ncumimaging. Lippincott Williams & Wilkins, 2000, 850p,
- Barnes PJ., Liew F. Y, Nitric oxide and asthmatic inflammation. I I Immunol, Today, 1995.-16,-pl 2&-130.
- Bartlct EJ. Brodie J.P., Wolf A.P., at al Reproducibility of cerebral metabolism measurement!: in resting human subjects. Ц J Cereb Blood Row Metab 1999 Vol.9 — p. 502−512.
- Beer S, Brune N" Kesselring J. Detection of anterior horn lesions by MRI in central European tick-bom encephalomyelitis. // J. Neurol. l999.-246.-pI 1 691 171.
- Beer S., Kesselring J. Die Multiple SklerOSc // Kanton Bern Fortschr. Neurol.Psychiat.1998.-56.-p390−397.
- Binder J., Frost J. Hammcke Т., Bcllgowan P., Springer J., Kaufman J., Possing E, Human temporal lobe activation by spccch and nonspeech sounds. // Cerebral Cortex-2000 -v.l0.-p5l2−528.
- Biondi A., Dormon! D. r Mamault С. Pathologic поп iu morale de la moelle. Editions Techniques, EMC. 1994- I9p.
- Bjartmar C" Battistuta J., Tcrada N. el al. N-acctylaspariate is an axon-Specffic marker of malurc while matter in vivo- A biochemical and immunohistochemical study on the rat optic nerve. // Ann, Neurol. 2002.-51,-p51−58.
- Blinkenberg M" Jensen C.V., Holm S. Paulson O.B., Sorcnsen P. S, A longitudinal study of cerebral glucose metabolism, MRI, and disability in patients with MS. // Neurology |999.-v53.-pl49-l53.
- Blinkenberg M., Rune K.(Jensen C, V. et al. Cortical cerebral metabolism correlates with MRI lesion load and cognitive dysfunction in MS. // Neurology- 2000 Vol 54 — p. 558−564.
- Blinkenberg M., Rune K., Jensen C. V, et al. Cortical cerebral metabolism correlates with MRI lesion load and cognitive dysfunction in MS. И Neurology- 2000 Vol.54 — p. 558−564.
- Blinkenberg M., Rune K., Jonsson A. ct al. Cerebral metabolism in a case of multiple sclerosis with acute mental disorder, H Acta Neurol Scand 1996 Nov- Vol.94 № 5 — p. 310−13.
- Bo I-., Dawson T.M., Wesselingh S, et al, Induction of nitric oxide synthase in dcmyclinating regions of multiple sclerosis brains. // Ann. Neurol, 1994- 36: 778−786,
- Boiko A., Kesselrmg J, Paly D-W. et al. Multiple sclerosis and public health / Educational and management implications. World Health Organization, Department of Mental Health, Neuroscicncc and Neurological Disorders, 1999, (2), 1−11.
- Bollengter F, Lowenthal A" Henroiin W. Bound and free light chains in subacute sclerosing panencephalitis and multiple sclerosis scrum and cerebrospinal (luid. // Z. Klin. Cbern, Klin. Biochcm. 1975-I3- 305−310.
- But J., Bark hoi F-, Lydclama J. et al. Natural course of MR spinal oord abnormalities in MS: 3 year follow-up. // Multiple sclerosis, 2004- 10 (suppl.2) SI 10.
- Hot J.C., Barkhof F., LyckJama G. et al. Differentiation of multiple sclcrosis from oiher inflammatory disorders and cerebrovascular disease: value of spinal MR imaging. // Radiology 2002- 223:46−56.
- Brny P.F. Integrin polymorphisms as risk factors for thrombosis. // Thromb Нас most., 1999- 82 (2): 337−344.
- Breiter S.N., Arroyo S., Mai thews V. P. el al. Proton MR spectroscopy in patients with seizure disorders, // Am. J, Neuroradiol. 1994. 15:373.
- Brcukclman A., Pol man C, de Slegtc R" Koet sicr J. Neuromyelitis optica (Devic's syndrome) — not always multiple sclerosis. // Clin, Neurol, Ncurosurg. 1988- 90:357−360.
- Brinar V. Diagnostic and therapeutic dilemmas, it Clin.Ncurol. Ncurosurg. 2004- 106: 180−186.
- Brinar V, The differential diagnosis of multiple sclerosis. If Clin.Ncurol. Ncurosurg, 2002- 104: 211−220.
- Brinar V, V. Non-MS recurrent dcmvelinaitng diseases. // Clin. Neurol. Neurosurg, .2004- 106: 197−210.
- Brod SA. Khan M, Bright J el at. Decreased CD3-mediated interieron-y production in relapsing-remilting multiple sclerosis, // Ann Neutol 1995- 37: 546—549.
- Brooks DJ" Leendere K. L, Head G., Marshall J., Legg NJ,. Jones T, / Studies on regional cerebral oxygen utilisation and cognitive function in multiple sclcrosis, // J Neurol Ncurosurg Psychiatry 1984 Nov — Vol.47 — № 11 — p.1182−91.
- Brosnan C.F., Baltistini L, Rainc CS. ct al. Reactive nitrogen intermediates in human neuropathology: an overview, // Dev. Ncurosci. 1994- 16: 152−161.
- Bruck W. MR I correlates of structural and immunapathological features оГ MS lesions, ft Multiple sclerosis 2004−10: suppl.2: SI05.
- Brack W., Bitsch A., Kotenda H-, et at. Inflammatory central nervous system demycli nation: correlation of magnetic resonance imaging findings with lesion pathology, // Ann Neurol. 1997- 42-. 783−793
- Bruhn H., Mictiaelis Т. Mcrboldt K l). et al. Monitoring cerebral glucose in diabetics by proton MRS |letter. // Lancet 1991- 337: 745−746.
- Brundin L, Svenungsson E. Morcos E, et al. CNS nitric oxide formation in cerebral SLE, И Ann Neural 1998- 44- 704−706.
- Brundtn L" Brismar H., Danilov АЛ. et al. Neural stem cells: a potential source for remyelination in neuroinflammatory disease. // Brain Pathol. 2003- 13- 322 328.
- Burgeon M.P., Gilden D.H., Owens G.P. B-cells in multiple sclerosis, Ц Frontiers in Bioscience 2004- 9- Jan 1: 786−796.
- But/kueven H, Brown J, Volgrin S et al. Cerebral atrophy in multiple sclerosis is strongly associated with duration of disease rather than disease severity. // Multiple Sclerosis 2001- 7 (suppl l):S40.
- Campi A. Filippi M., Comi G. ct al. Acute transverse myelopathy: spinal and cranial MR study with clinical follow-up. // Am. J. Neuroradiol. 1995- 16: 115 123.
- Carpenter M.B. Core Text of Neuroanatomy. Williams and Wilkins, 1995, 481 p.
- Cavada C. and Goldman-Rakie P. Posterior parietal cortex in rhesus monkey: II. Evidenca far segregated corticuspinal networks linking sensory and limbic areas with the frontal lobe. H J. Сотр. Neurol. 1989 — Vol.287 — p. 422−445.
- Chahriat Н. CADASIL: Cerebral Autosomal Dominant Adenopathy with Subcortical Infarcts and Lcucoencephalopathy. // In: Primer on Cerebrovascular diseases. Eds.: Welch K.M.A., Caplan L.R., Reis D.J., Siesjo B. K" Weir B. Academic Press, 1997, p.410−413.
- Challoncr PB. Smith KT, Parker JD et at. Platjuc-associaled expression of human herpes virus 6 in multiple sclerosis. // Proc Natl Acad Sci USA 1995- 92: 7440—7444.
- Chao C, C" Hu S" Molitor T. Wr et al, Activated microglia mediate neuronal cell injury via nitric oxide mechanism. Hi. Immunol. 1992- 149: 2731−2736.
- Charcot J.-M. Histologic de la sclerose en plaques, // Gaz. Hosp, 1868- 141- 554−558,
- Chen C., Ro L.S. Chang C. N, et al. Serial MR. studies in pathologically verified Balo’s concentric sclerosis. // J, Compul. Assist. Tomogr, 1996- 20: 732−735.
- Clausen J. Endogenous retroviruses and MS: using ERVs as disease markers. // Int. MS 1.2003- 10: 22−28.
- Comi G., Filippi M., Rovaris M. et al. Clinical, neumphysio logical, and magnetic resonance imaging correlations in multiple sclerosis. // J. Neurol., Neurosurg., Psychiair. 1998- 4(suppl.): S21-S25.
- Compston A. The pathogenesis and basis for treatment in multiple sclerosis, if Clin.Neurol. Neurosurg. 2004- 106- 246−248.
- Cree B.A., Goodin D.S., Hauser S, L. Neuromyelitis optica, /I Scmin. Neurol, 2002- 22- 105−122.
- Dale R.C., de Sousa W.K., Chong T.C. et al. Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children, if Brain, 2000- 123: 2407−2422.
- Danilov A.I., Andersson M. Bavand N, el al. Nitric oxide metabolite determinations reveal continuous inflammation in multiple sclerosis, ft J. of NeuroimmunoL 2003,136:112−118,
- Davie С," Barker G., Webb S. et al. Persistent functional delicti in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. // Brain 1995 — Vol.118 -p. 1583−92.
- Davics M.B., Williams R, Haq N. et al. MRI of optic nerve and postchiasmal visual pathways and visual evoked potentials in secondary progressive multiple sclerosis. Neuroradiology 1998- 40:765−770.
- Davis LE, Spirochetal Disease. // In- Diseases of the Nervous System: Clinical Neurobiology- Edited By A. K-Asbury, G.M.McKhann, W.I.McDonald / W.B.Saundcrs Company 1992, 1620P- pp. 1359−1370.
- Dawson V. L*, Brahmbatt H.P., Mong J. A-. Dawson T-M. Expression of inducible nitric oxide synthase causes delayed neurotoxicity in primary mixed neuronal glial cell cultures. // Neuropharmacology 1994- 33: 1425−1430.
- De Bustos F., Navarro J.A., de Andres C. et al. Cerebrospinal fluid nitrate levels in patients with multiple sclerosis. // Eur. J. Neurol. 1999- 41- 44−47.
- De Carli Ch" Menegus M.A., Rudick R A. Free light chains in MS and infections of the CN5. // Neurology, 1987- 37: 1334−1338.
- De Seze J., Stojkovic T-, Ferriby D. ct al. Devic’s neuromyelitis optica: clinical, laboratory MRI and outcome profile. // Neurol. Sci. 2002- 197: 57−61.
- De Seze L" Vcrmcrsch P, Sequential MR! fo)|oiv-up of multiple sclenwys before the clinical phase. // Multiple Sclerosis, 2004. V.10 (suppl. 2) — St94.
- Devinsky О., Cbo Е., Petilo С, Price R, Herpes Zoster myelitis, tt Brain, 1991: 114:1181−1196.
- Dictionary of Multiple Sclerosis. Eds.: Blumhardt L.D., Lin X, Constantincsku C.S., Giovannoni G-, Kurtatke J.F., Li D.K.B., Sorensen P, S" Ebcrs G.C., Kesselring J., Lassmann H., Ш С., Whitaker J.N. Martin Dunitz, 2004. P.254.
- Dolci A. Scrra C" Mamcli G. ct al. Multiple scterosis-associated retrovirus (MSRV) in Sardinian MS patients. H Neurology. 2002- 58: 471−473.
- Doyon J., Owen A.M., Petridcs M., Swklas V. t Evans AC. Functional anatomy of vasomotor skill learning examined with positron emission tomography, // Eur. J. NeuroscL 1996 — Vol, 6 — p, 637−648.
- Drulovic J., Dujmovic L, Mesaros S. ct al. Raised cerebrospinal fluid nitrate levels in patients with multiple sclerosis: no correlation to disease activity. // Mult. Sclcr. 2001- 7: 19−22.
- Duquette P, Murray TI. Pleines I et al. Multiple sclerosis in childhood: clinical profile in 125 patients. //J Pediatrics 1987. Ill: 359−363.
- Ebers GC, Sadovnick AD. Risch NJ ct at. A genetic basis for familial aggregation in multiple scteiosis. // Nature 1995- 377: 150—151.
- Ebten F" Poremba M., Grodd W. et al. Myeliiwclastic diffuse sclerosis (Schilder's disease): clinicoradiotogic correlations. H Neurology 1991- 41- 589 591.
- Edwards S-, Zvartau Mr, Clarke H, ct al. Clinical relapses and disease activity on magnetic resonance imaging associated with viral upper respiratory iract infections in multiple sclerosis. H J. Neurol, Neurosurg, Psychiatry 1998- 64- 736−741,
- Ehrcn I., Hosscini A. t Lundberg J.O. Wiklund N.P. Nitric oxide: a useful gas in the detection of lower urinary tract inflammation. //J. Urol. 1999- 162 (2): 327 329.
- Ehrlich GD. Glaser JB, Вгуг-Gornia V et al. Multiple sclerosis, retroviruses, and PCR, // Nerology 1991- 41: 335—343.
- Emerson R. G, Evoked potentials in clinical trials for multiple sclerosis. // J. Clin. Neurophysiol. 1998- 15- 109−116″
- European Study Group on Interferon beta-lb in Secondary Progressive MS. Placebo-controlled multicentre randomised trial of interferon beta-lb in treatment of secondary progressive multiple sclerosis. H Lancet 1998- 352- 1491−1497.
- Fagnart O.C., Sindic CJ.M. Lalerre C. Free kappa and lambda light chain levels in the CSF of patients with MS and other neurological diseases. // J. Neuroimmunol. 1988- 19 (1,2) — 119−132.
- Fazekas F-, Barkhof F., Filippi M. cl al. The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis, H Neurology 1999- 53- 448−456.
- Fazckas F" Barkhof F., Filippi M. cl al. The contribution of magnetic resonance imaging to the diagnosis multiple sclerosis. // Neurology 1999 -Vol.53 — p, 448−456.
- Fuck as F., Offcnbacher H., Fuchs S. et al. Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis. // Neurology 1988- v.3B: p. 1822−1825.
- Ficschi C, Gaspcrint C, Ristori G et at. Patients with clinically definite multiple sclerosis, white matter abnormalities on MRI, and normal CSF: if not multiple sclerosis, what is it? // J Neurol Neurosurg Psychiatry, 1995- 58(2): 255—256.
- Fieschi С." Gasperini C" Ristori G, Differential diagnosis in multiple sclerosis. ft In: «Multiple Sclerosis: Clinical Challenges and Controversies» edited by AJ. Thompson, C. Polman, R. Hohlfdd- Martin Dunitz, 1997, 350P, 65−86.
- Filippi M-. Falini A., Arnold D, et al. Magnetic resonance techniques for the in-vivo assessment of MS pathology: consensus report of the white matter study group, I! J MRI 2004,
- Filippi M-. Paty D.W., Kappos L., ct al. Correlations between changes in disability andT2-weighled brain MRI activity in multiple sclerosis: a follow up study. // Neurology 1995 — Vol.45 ¦ p. 255−260.
- Filippi M" Rocca M.A., Comi G. The use of quantitative magnetic resonance techniques to monitor the evolution of multiple sclerosis. // Lancet Neurology. 2003- 2:337−346.
- Filippi M., Rocca M-A-. Falini A. et al. Correlations between structural CNS damage and functional MRI changes in primary progressive MS. // Neuroimage 2002 — Vol Л 5 — p. 537−546.
- Filippi M. Tortorclla G, Bozz&li M. Normal appearing white matter changes in multiple sclerosis. The contribution of magnetic resonance techniques. // Multiple Sclemsis 1999 — Vol.5 — p. 273−282.
- Fitzgerald M., Coleman L, Recurrent myelinoclastic diffuse sclcrosts: a case report of a child with Schilder s variant of multiple sclerosis. // Podia tr. Radiol. 2000- 30: 861−865.
- Gildcn D.H., Devlin M.E., Burgoon M.P., Owens G.P. The search for virus in multiple sclerosis brain, H Multiple Sdcrosis 1996- 2: 179−183.
- Glide n D.H., Kkinschmtdt-DcMastcrs B.K., LaGuacdia J.J. et al. Neurologic complications of the reactivation of varicella-zoster virus, // New Engl. J. Med. 2000- 342- 635−645.
- Giobbia M, Carniato A" Scot ton P. et al, Cytomegalovirus-associatcd transverse myelitis in a non-immunocompromised patient, // Infection, 1999- 27: 228−230.
- Giovannoni G. Cerebrospinal fluid and serum nitric oxide metabolites in patients with multiple sclerosis, /I Mull. Scler. 1998- 4: 27−30.
- Giubilei F" Sarrantonio A., Tisei P et al. Four-year follow-up of a case of acute multiple sclerosis of a Marburg type. // Iial- J. Neumsci. 1997- 18: 163−166.
- Gnann J. Mumps virus diseases. In: McKcndal! R-. Slroop W. (Eds.) Handbook of ncurovirology. New York, M, Dekker, 1994- 563−573,
- Grady C.L., Berg G. t Carson R.E., et al. Quantitative comparison of cerebral glucose metabolic rate|s from two positron emission tomographs. //J Nucl Med -1989-VoL30-p. 1386−1392.
- Grafton S.T., Haseltine E., ivry R, Functional mapping of sequence learning in normal humans. Ц J. Cogn. Ncurosei. 1995 — Vol. 7 — p. 497−510,
- Gray F., Chimelly L., Mohr ei al. Fulminating MS-likc Icucoencephalopathy revealing human immunodeficiency virus infection. H Radiology 1996- 198: 546−551.
- Griffin D, E. Encephalitis, myelitis, and neuritis, // In: Mandell G.L. Bennett J. E, Dolin R. (Eds.) Mandell, Douglas and Bennett’s principles and practice of infectious diseases. Churchill Livingstone, 2000: 1009−1016.
- Griffin D.E., Johnson R, T. Host Responses to Infection of the Nervous System. Ц In- Asbury A.K., McKhann G. M-, McDonald W.l.(Eds) Diseases of the Nervous System: Clinical Neurobiology, (W.B-Saunders Company 1992- 1288−1297,
- HainfcIlnerJ.A., Schmidbauer V, Schmutzhard E. et al. Devie’s neuromyelitis optica and Schilder’s myelinoclastic diffuse sclerosis. Ц J. Neurol Neurosurg Psychiatry 1992- 55: 1194-Ц96.
- L Hamilton R. Tile human IgG subclasses. Calbiochem Corporation, 1989- 76p. l92,Hartung H.-P., Grossman R. ADEM: distinct disease or part of the MS spectrum? // Neurol. 2001- 56:1257−1260
- Hawkins S.H. Primary progressive MS/Re lapsing-remitting MS: one or two diseases? It Multiple sclerosis, 2004- 10 (suppl.2) Si09.
- Helms O. Volume correction for edema in single-volume proton MR spectroscopy of contrast-enhancing multiple sclerosis lesions. // Magn. Reson. Med, 2001- 46: 256−263.
- Hcmmcr B. Body fluid markers in MS- arc we closer to understanding the pathogenesis of multiple sclerosis? // Multiple Sclerosis, 2004- 10 (S2) — S108.
- Henriksson F" Jonsson B. The economic cost of multiple sclerosis in Sweden in 1994, // Pharmacoeconomics 1998,13:597−606,
- Hillert J" Groaning M. Nyland H. et al. An immunogenctic heterogeneity in multiple sclerosis, // J, Neurol-, Neurosurg., Psychiatry 1992- 55: 887−890.
- Hilton D.A., Love S-. Fletcher A., Pringle J.H. Absence of Epstein-Barr virus in multiple sclerosis as assessed by in situ hybridization, // J. Neurol., Ncurosurg., Psychiatry 1994- 57: 975−976.
- Hinson V.K., Tyor W.R. Update on viral encephalitis. // Curr. Opinion in Neurol. 2001- 14- 369−374.
- Hohlfeld R. r KcTschcnsteiner M-, Stadelmann C. ct al. The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis. // J. Neuroimmunnl. 2000- 107: 161−166.
- Hohlfeld R. Kerschcnstciner M" Stadelmann C, ct al. The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis, // J. Ncuroimmunol., 2000- 107: 161−166.
- Holland N.R., Power C-, Mathews V. P et al. Cytomegalovirus encephalitis in acquired immunodeficiency syndrome (AIDS). H Neurology, 1994- 44: 507 514.
- Holtas S" Reiser M.F., Stabler А. Позвоночник В кн.: Pettersson H. (Ред.) Общее руководство по радиолошн. М. 1996, с.297−370.
- Hommcl М- Small Artery Occlusive Disease, In: Primer on Cerebrovascular diseases, Eds.: Welch K.M.A., Capiat) L.R., Re is DX, Siesjo U.K., Weir B. Academic Press, 1997, p.303−310
- Howe F.A., Maxwell RJ., Saunders D.E. et al. Proton spectroscopy in vivo. // Magn. Rcson, 0.1993- 9: 31−59.
- Ikeda M. Sato 1-. Matsunaga T et al. Cyclic guanosine monophosphate (cGMP), nitrite and nitrate in the cerebrospinal fluid in meningitis, multiple sclerosis and Guitlain-Barrc syndrome. // Intern. Med. 1995- 34: 734−737.
- Itoyama Y. ct al. Distribution of papovavirus, myelin-associated glicoprotcin and myelin basic protein in progressive multifocal leukocnccphalopathy lesions. И Ann, Neurol, 1982- 11: 396−407.
- Jackson G.D., Connelly A, Magnetic resonance imaging and spectroscopy. И Current Opinion in Neurology. 1996- 9- 82−88.
- Johansson G, Svensson M., Walistedt L. et al. Neural stem cells in the adult human brain, U Expcrim. Cell research. 1999- 253: 733−736.
- Johnson A.W.r Land J.M., Thompson EJ. et al. Evidence for increased nitric oxide production in multiple sclerosis, // J. Neurol., Neurosurg., Psychiatry, 1995- 58:107.
- Johnson M.D. Lavin P., Whetsel! W.O., Jr, Fulminanl monophasic multiple sclerosis, Marburg’s type. // J. Neurol., Neurosurg, Psychiatr. 1990- 53: 918 921.
- Jones E. Patho-anatomic and histo pathologic character of lesions in the central nervous system in man following anti-rabies treatment. // J. Ncuropathol, Exp, Neurol. 1958- 17: 327−328.
- Joy J,?" Johnston R.B. Eds. Multiple Sclerosis: current status and strategies for the future. National Academy Press, Washington. D.C.2001,438p.
- Jucptncr M" Frith C.D., D.J. Brooks DJ. Frackowiak R.S.I., Passingham R E. The anatomy of motor learning. II. Subcortical structures and teaming by trialand error. // J. Neurophysiol. 1996 — Vol. 77 — p. 1325−1337.
- Kantarci O.H., Wcinshenkcr B.G. Prognostic factors in mulliplc sclerosis. In: Cook S. (Ed,). Handbook of multiple sclerosis. New York, 2001- 449−462.
- Kellcy R.E. CNS vasculitis. // Frontiers in Bioscience, 2004 — 9 — 946−955.
- Kc pes J J. Large, focal, tumor-like demyelinating lesionsof the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients. // Ann. Neurol. 1993- 33- 18−27,
- Kcrmode A.G., Tofts P. S., Thompson A.J. et al. Heterogeneity of blood-brain barrier changes in multiple sclerosis: An MRI study with gadolinium-DTPA enhancement.// Neurology 40: 229−235,1990.
- Kerr D. A, Ayetey H. Immunopathogenesis of acute transverse myelitis, // Curr. Opin. In NcuroL, 2Ш2- 15- 339−347.
- Kesselring J., Miller l>, H-. Robb S-A. et al. Acute disseminated encephalomyelitis MRI findings and tbc distinction from multiple sclerosis. // Brain, 1990−113:291−302.
- Khan O, Zvanau-Hind M" Caon C, Ching W, Lisak R, Tselis A. Intcrcaudate nucleus ratio (ICR) in MS patients as a linear measure of brain atrophy. // Multiple Sclerosis Suppl, P24I.
- Kidd D-. Barkhof F." McGmaell R. et a! Cortical lesions in multiple sclerosis. H Brain, 1999- 122: 17−26.
- Kidd D., Thorpe J.W., Thompson AJ. el al. Spinal cord MRI using multi-array coils and fast spin-echo. II. Findings in multiple sclerosis. // Neurology 1993- 43: 2632−2637.
- Kira J-L, Kanai T-, Nishimura Y. el al. Western versus Asian lypcs of multiple sclerosis immunogeneiically and clinically distinct disorders. //Ann. Neurol. 1996- 40: 569−574.
- Knaap V. d M.S., Valk J. Magnetic Resonance of Myelin. Myclination and Myelin Disorders. Berlin. Springer, 1995, 444p,
- Knebuseh M., Slrassbourg H-, Rciners K. Acute transverse myelitis in childhood: nine cases and review of the literature- // Dev. Med. Child. Neurol. 1998- 40: 631−639.
- Kolson D-L-, Gonzalcz-Scarano F, Endogenous retroviruses and multiple sclerosis. // Ann. Neurol. 2001- 50: 429−430,
- Koprowski H, Zheng Y.M., Heber-Kalz E. et al. In vivo expression of inducible nitric oxide synthase in experimentally induced neurological diseases. Ц Proc. Natl. Acad. Sci. USA 1993- 90: 3024−3027.
- Kornelissc R.F., Hoeckman K., Visser J.J. et al. The role of nitric oxide in bacterial meningitis in children, //J. Infect. Dis. 1996- 174: 120−126.
- Kristensen В., Malm J., Ntlsson Т.К. ct al. Increased fibrinogen levels and acquired hypofibrinolysis in young adults with ischemic stroke. // Stroke, 1998- 29: 2261−2267.
- Kurtzkc J.F. On the evaluation of disability in multiple sclerosis. // Neurology, 1961″ 11:686−694.
- Kuruke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) t (Neurology 1983- v.33: pЛ444−1452.
- Kuril) S., Cakmaktf J-JL, Dirik E., Kovanlikaya A- Schilder’s disease: case study with serial neuroimaging. /I J. Child, Neurol.2003- 18 (1): 58−61,
- Kwon N.S., Sluehr D.J., Naihan C, F. Inhibition of tumor cell ribonucleotide reductase by macrophage-de rived nitric oxide, // J- Exp. Med. 1991- 174: 761 767,
- Landrigan PJ-, Witte J. J, Neurologic disorders following live measles-virus vaccination.// JAMA, 1973- 223- 1459−1462,
- Lassmann H, ClassiПса"ion of demyelinating diseases al the interface between etiology and pathogenesis. // Curr. Opin, In Neurol-, 2001- 14: 253−258.
- Lassmann H. Hypoxia-like tissue injury as a component of multiple sclerosis lesions. //J, of Neurol. Sci. 2003- 206- 187−191,
- Lassmann H-, Bruck W, Lucchinctti C. Hclcrogcneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. // Trends in Molecular Medicine. 2001- 7(3) — 115−121.
- Lee M" Reddy H., Johansen-Berg H., Pendlebury S" Jenkinson M, Smith S" et al. The motor cortex shows adaptive functional changes to brain injury from multiple sclerosis. // Ann. Neurol, 2000 — Vol.47 — p. 606−613,
- LcOCwU L" Comi G, Ncurophysiological investigations in multiple sclerosis.// Current Opinion in Neurol, 2000- 13: 255−261.
- Levin L-L, Munger K. L, Rubcrtonc M, V. et al. Mulliple sclerosis and Epstcin-Barr virus. // JAMA, 2003- 289- 1533−1536.
- Levine S.R. Antiphospholipid Antibody Syndrome, H In: Primer on Cerebrovascular diseases. Eds.- Welch K.M.A., Caplan L.R., Rets DJ., Sicsjo B.K., Weir B. Academic Press, 1997, pJ81−384.
- Lcvinson S.S., Keren D.F. Free light chains of immunoglobulins: clinical laboratory analysis, f! Clin, Chetn, 1994- 40- 1869−1878,
- Link IL, Baig S., Jiang Y.-P. et al, B-cellsand antibodies in MS, II Research in Immunol. 1989- 140: 219−226.
- Link H" Tibbling G, Principles of albumin and IgG analyses in neurological disorders. II. Evaluation of IgG synthesis within the CNS in MS, H Scand J О in Lab. l nvest.1977- 37 385−390.
- Lipton S.A., Choi Y.-B., Pan Z.H. A redox based mechanism for the neuroprotective and neurodestructive effects of nitric and related nitroso-compounds. // Nature 1993- 364: 626−632.
- Litvan l" Grafman J. Vendrell P. r Marline/ J.M. Slowed information processing in multiple sclerosis,// Arch Neurol 1988 — Vol.45 — p. 281−185.
- Lo R" Feasby T, Multiple sclerosis and autoimmune diseases, ft Neurology. 1983- 33- 97−98.
- Lockwood A.H. Editorial- Invasivness in Studies of Brain Function by Positron Emission Tumography (PET). // J. Ccrcb. Blood Flow Metab. 1985 -Vol, 5-p. 487−489
- Logigian JL10 most commonly asked questions about neurologic Lyme disease, Ц The Neurologist, 1999, У.5, No I, pp, 44−50
- Longstrcth W.T., Roscndaal F.R., Siscovick D.S. et al. Risk of stroke in young women and two prothrombolic mutations- Factor V Leiden and prothrombin gene variant (G20210A). // Stroke, 1998- 29- 577−580.
- LoPachin RM., Lchning EJ. Mechanism of calcium entry during axon injury and degeneration. !lToxicol, Appt Pharmacol., 1997- 143- 233−244.
- Lorente J A, Landin L, Renes E, et al. Role of nitrkr oxide in the hemodynamic changes of sepsis, Crit, Care Med. 1993- 21: 759−767.
- Losseff N.A., Wang L., Lai H-M, et al, Progressive cerebral atrophy in multiple sclcrosis: a serial MRI study, it Brain -19% Vol.119 — p. 2009−2019.
- Lu W., Zhao B, Postvaccinal neurological complications. // Clin, Med. J, 1984- 97: 447−450.
- Markus H.S., Lythgoc DJ-, Qstegaard L. el al- Rcduccd cerebral blood flow in white matter in ischemic leucoaraiosis demonstrated using quantitative exogenous contrast based perfusion MRI, H J, Neurol., Neurosurg., Psychiatry. 2000- 69: 48−53,
- Matthews P.M. Pioro E" Narayanan S, et al. Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy. И Brain. 1996- 119 (3): 715−722.
- McAlpine D. Acute disseminated encephalomyelitis: its sequelay and its relationship to disseminated sclerosis. // Lancet, 1931- 846−852.
- McDonald W.I., Thompson A. J, How many kinds of multiple sclerosis are there?. // In: Multiple Sclerosis- Clinical challenges and controversies, Eds.: Thompson A.J., Polman C, Hohlfcld R. Martin Dunii*, 1997,35−42.
- McDonald Wl, Compston A, Edan G ct al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the internalional panel on the diagnosis of multiple sclerosis. // Ann Neurol 2001−50:121−127.
- McDonnell G.V., Cabrera-Gomez, Calnc D-B, ct al. Clinical presentation of primary progressive multiple sclerosis 10 years after incidental findings of typical magnetic resonance imaging brain lesions, it Multiple Sclerosis. 2003- 9:204−209.
- McDonnell G.W., Hawkins S.A. Primary progressive multiple sclerosis: a distinct Syndrome? // Multiple sclerosis. 1996- 2 (3): 137−141.
- Mendell J.R., Kolkin S., Kissel J.T. et al. Evidence for central nervous system demyelination in chronic inflammatory dumyelinating polyradiculoneuropathy. Ц Ncurotogy. 1987- 37: 1291−1294.
- Merrill J.E., Ignairo LJ" Sherman M. P, et al. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. И J. Immunol, 1993- 151: 2131−2141.
- Mesulam M. From sensation to cognition. // Brain 1998 — Vol.121 — p. 10 131 052.
- Mesulam M and Mufson E. The insula of reil in man and monkey: architectonics, connectivity, and function. // In: Cerebral Cones: assotiation and auditory cortices (PctTS a. and Jones E., Eds.) Plenum Press. New York- -1985 -p. 179−226,
- Miki Y" Grossman R. L, Udupa J.K. cl al. Differences between relapsing-remitting multiple sclcrosis and chronic progressive multiple sclerosis as determined with quantitative MR imaging. U Radiology 1999 — Vol.210 — p. 769−774.
- Miller A., GJass-Marmor L., Abraham M. cl al. Bio-markers of disease activity and response to the therapy in multiple sclerosis. // Clin. Neurol. Ncurosurg. 2004- 106: 249−254.
- Miller A., Shapiro S. Gcrshtcin R. et al. Treatment of multiple sclerosis with Copolymer-1 (Copaxone): implicating mechanisms о ГШ to Th2Th3 immune deviation. // J, of Neuioimmunology 1998- 92- 113−12).
- Miller D.H. Filippi M., Fazekas F. et al. The role of MRI within diagnostic critcria for multiple sclerosis- a critique. // Ann. Neurol, 2004- 56- 273−278.
- Miller D.H., Kesselring J., McDonald W.I., Paty D.V., Thompson A.J. Magnetic Resonance in Multiple Sclerosis. Cambridge University Press, 1997- 200p.
- Miller H., Evans M. Prognosis in acute dissrminated encephalomyelitis with a nolc on neuromyelitis Optica. // Quart. J. Med. (NS) 1953- 22.
- Minmdola P., Stefan A., Brambilla E. et al. Absence of human herpesvirus 6 and 7 from spinal fluid and scrum of multiple sclerosis patients. // Neurology, 1999- 53:1367−1368.
- Mochizuki A., Hayashi A., Hisahara S., Shoji S. Steroid-responsive Devic’s variant in Sjogren’s syndrome. // Neurology, 2000- 54: 1391−1392,
- Moore G.R., Neumann P.E., Suzuki K. et al. Bale’s concentric sclerosis: new observations on lesion development. II Ann. Neurol. 1985- 17: 604−611.
- Moore P. Immune Mediated Neurovascular Disease. H In: Primer on Cerebrovascular diseases. Eds.- Wclch K.M.A., Caplan L.R., Reis DJ., Sie&jo
- B.K., Weir B. Academic Press, 1997, p.376−381.
- Moral E" Alonso-Magdalena L., Carmona O. ct я I. Multiple sclerosis with laic and very lale onset. // Multiple Sclerosis, 2004. V. U) (suppl 2): SI02,
- Muchnik S,. ftugglo C., Cristiano E, ct al. MR venography may help to distinguish multiple sclerosis from hypoxic ischemic white matter lesions. // Multiple sclerosis. 2003, v.9, September, suppl.2., p,280.
- Multiple sclerosis: clinical challenges and controversies, Eds.: AJ.Thompson.
- C.Pol man. R. Hohlfeld. Mart in Dunitz, 1997, P.360.
- Murphy S., Simmons M. L, Agullo I et al. Synthesis of nitric oxide in CNS glial cells. // Trends Ncurosci. 1993- 16: 323−328.
- Murthy S.N.R., Fadcn U.S., Cohen M.E. Acute disseminated encephalomyelitis in children. // Pediatrics, 2002- 110, N2:21−29.
- Nagai M" Jacobson S. Immunopathogenesis of human T celt lymphotropic virus lype l-associatcd myelopathy. // Curr, Opin- In Neurol, 2001- 14- 381 386.
- Nandini M" Gourie-Dcvi M. Shankar S. et al. Balo’s concentric sclerosis diagnosed intravitum on brain biopsy. II Clin. Neurol., Neurosurg. 1993- 95: 303−309.
- Narayana P.A., Wolinsky J.S., Jackson EF" McCarthy M. Proton MR spectroscopy of gadolinium-enhanced multiple sclerosis plaques. Ц J. Magn. Rcson, Imaging 1992, 2: 263−270.
- Nathan C.F., Hibbs J.B. Role of Nitric Oxide synthesis in macrophages antimicrobial activity. // Curr. Opin. Immunol, 1991- 3 (1): 65−70.
- Neihlcr G., Karris Т., Davis Т., Roos K, Fulminant multiple sclerosis, U AJ.N.R. 1992- 13- 1547−1551.
- Neighbor PA, Miller AL, Bluom BR. Interferon responses of leucocytes in multiple sclerosis. Ц Neurology 1981- 31: 561—566.
- Nordahl Т.Е., Slein MB., Chawki B" Scmpte W, E" Andrcason P., Zamctkin A-, Uhdc T.W., Cohen R.M. Regional Cerebral Metabolic Asymmetries Replicated in an Independent Group of Patients with Panic Disorders // Biol Psychiatry 1Ш — Vol.44 — p. 998−1006
- Norrby E, Viral antibodies in multiple sclerosis. Ц Prog, Med. Virol. 1978- 24- 1−39.
- Noseworthy J.H., Lucchinetti C" Rodriguez M., Wcinshcnkcr B.G. Multiple sclerosis. II N. Engl J. Med. 2000- 343: 938−952,
- Panitch H, The importance of viral infections and vaccinations in multiple sclcrosis. // In: Thompson AJ. Pol man C, Hohlfeld R (Eds.) Multiple sclcrosis: Clinical Challenges and Controversies. (Martin DunitZ, 1997) 131 144,
- Panilch US, Hirsch RL, Schindlcr J et at. Treatment of multiple sclerosis with gamma interferon: Exacerbations associated with activation of the immune system. It Neurology 1987- 37: 1097—1102,
- Panlano P., laneni G" Caramia F. et al. Cortical motor reorganization after a single clinical attack of multiple sclerosis. // Brain 2002 Jul — Vol.125 — № 7 -p. 1607−15.
- Pantoni L., Garcia J.H., Gutierrez J.A. Cerebral white matter is highly vulnerable to ischemia. // Stroke, 1996- 27: 1641−1647.
- Papais-Alvarcnga RM-, Miranda-Santos C.M., Puceioni-Sohlcr M- et al. Optic neuromyelitis syndrome in Brazilian patients. // J. Neurol., Ncurosurg., Psychiair, 2002- 73- 429−435,
- Passingham R, E, The frontal lobes and voluntary action. // Oxford Univ Press, Oxford-1993.
- Paty D.W., Boiko A.N. Vorobeychik G. K, Multiple sclerosis with early and late disease onset. In: McDonald W.I., Noseworthy J.H.(Eds). Multiple Sclerosis, 2. Elsevier Sciences (USA), 2003- 285−302.
- Paty D, W" Oger JJ.F., Kastrukoff L. F, et al. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding and CT, It Neurology 1988- v38: p. 180−185.
- Paulesu E., Perani D" Fazio F. et al. Functional basis of memory impairment in multiple sclerosis: a 11 SFjFDG PET study. Neuroimage, 1996-, 4- 87-%,
- Perron H., Geny C-. Laurent A. ci al. Leptomeningeal cell line from multiple sclerosis wilh reverse transcriptase activity and viral particlcs. // Res. Virol. 1989- 140- 551−561.
- Pczzoli A, Pascali E. Bcnce Jones proteinuria in multiple sclerosis. // Clin. Chern. 1987- 33- 1923−4.
- Piyasirisilp S" Hemachudha T. Neurological adverse events associated with vaccination, // Cuir. Opin. in Neurol. 2002- 15- 333−338.
- Poser C, Diffuse-disseminated sclerosis in the adult. // J. Neuropathol. Exp. Neurol. 1957- 16: 61−78.
- Poser C. Multiple sclerosis: Observations and reflections a personal memoir, //J. Neurol.Sci. 1992- 107: 127−140.
- Poser G, van Bogaert L. Natural history and evolution of the concept of Schilder’s diffuse sclerosis. Acta Psychial. // Neurot, Scand. 1956- 21: 285 331.
- Poser C.M. el al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. // Ann Neurol 1983, v.13: 227−231.
- Poser C. M, Myclinoclastic diffuse sclerosis. U Itj: Koelsier J. C* ed. Kandbbok of Clinical Neurology. Amsterdam: Elsevier Science, 1985: 419−428.
- Poser C.M. The epidemiology of multiple sclcrosts- a general overview. U Ann, Neurol. 1994- 36 (52): S231−243.
- Poser C.M., Brinar V.V. Diagnostic criteria for multiple sclerosis: an historical review.//Ctin Neurol. Neurosurg. 2004- 106: 147−158,
- Poser CM., Brinar V.V. The nature of multiple sclerosis, // Clin. Neurol., Neurosurg. 2004- 106: 159−171,
- Poser C, M" Youtries F., Carpentier M., Aicardi J, Schilder’s myelinoclastic diffuse sclerosis. // Pediatrics. 1986- 77: 107−112.
- Poser S. Multiple sclerosis. An analysis of 812 cases by means of electronic data processing. Springer, 1978.
- Potegics P., Corssmit N, Epstein-Barr virus and the nervous system. // Curr. Opinion in Neurol. 2000- 13:301−304.
- Rainetcau O., Schwab M, Plasticity of motor systems after incomplete spinal cord injury. II Nat. Rev. Neurosci 2001 — Vol.2 — p. 263−273.
- Rcddy H., Narayanan S., Amoulcilts R., Jenkinson M., Antel J., Matthews P. Evidence for adaptive functional changes in the cerebral cortex with axonal injury from multiple sclerosis. H Brain 2000a. — Vol. 123 — p. 2314−2320.
- Reddy H., Narayanan S., Matthews P., Hoge R., Pike O., Duquette P., et al. Relating axonal injury to functional recovery in MS. // Neurology 2000b -Vol-54-р. 236−239.
- Rcdford E." Kapoor R., Smith K, Nitric oxid donors reverstbly block axonal conduction: dcmyclinaled axons arc especially susceptible. Ц Brain, 1997- 120- 2149−2157.
- Rceders J.A.W. (Ed.) Diagnostic imaging of AtDS. Stuttgart: Thieme, 1992, I36p.
- Rcuner K.H., Ruf A. Grau A, ct al, Prothrombin gene G20210A transition is a risk factor for cerebral venous thrombosis. // St roke, 1998- 29: 1765−1769.
- Revcsz T, Kidd D, Thompson AJ et at, A comparison of the pathology of primary and secondary progressive multiple sclerosis. // Brain. 1994- 117: 756—765.
- Riisc T. Is the incidence of multiple sclerosis increasing? // In: Multiple Sclerosis: Clinical challenges and controversies. Eds.: Thompson A.J., Polman C., Hohlfeld R, Martin Dunitz, 1997.1−12.
- Riisc Т., Gronning M., Fernandez O. cl al. Early prognostic factors for disability in multiple sclerosis, a European multicentcr study. // Acta Neurol. Scand, 1992−85:212−218.
- Rocca M.A. Mastronardo G., Horsficld M. A- et al. Comparison of three MR sequences for the detection of cervical cord lesions in patients with multiple sclerosis.// Am. J. Neuroradiol, — 1999- 20- 1710−1716.
- RodriguczM. Lucchinetti C.F. Is apoptotic death of the oligodendrocyte? critical event in the pathogenesis of multiple sclerosis? /I Neurology, 1994- 53 (8): 1676−1682.
- Rosenberg G, A. White Matter Disorders. // In: Primer on Cerebrovascular diseases. Eds: Welch K.M.A., Caplan L. R, Reis D.J., Sicsjo B.K., Weir B. Academic Press, 1997, p.371−376,
- Rosendaal F.R., Koster Т., Vandenbroucke J. P, et al. High risk of thrombosis in patients homozygous for factor V Leiden. H Blood, 1995- 85: 1508−1518.
- RosicareJIi В., Magliozzi R., Columba-Cabczas S. Et al. ?)etection of inlramcningcal lymphoid-Iike follicles in multiple sclerosis and experimental autoimmune encephalomyelitis, (f Multiple sderosis, 2003, v.9, September, suppL2.p.228,
- Rovirq A" Tintore M" Fraschcri L, cl al. Early brain MRI in clinically isolated syndromes. Ц Multiple sclerosis, 2004- 10 (suppl.2). Sep.: S105.
- Rudick R.A., French C.A., Breton D., Williams G, W, Relative diagnostic value of CSF к chains in MS: comparison with other immunoglobulin tests, U Neurology, 1989- 39:964−968.
- Rudick R.A., Pallant A" BidlaCk J., Hcmdon R. Free к light chains in MS spinal nuid, // Ann. Neurol. 1986:20: 63−69.
- Sasire-Garriga J. Ingle G, T" Chard D-T- et al. Grey and white matter atrophy in clinically early PPMS: one year follow-up study. // Multiple sclerosis, 2004- 10 (suppl-2) SI 10.
- Sawcer S., Robertson N. Compston A, Genetic epidemiology of multiple sclerosis, II In: Multiple Sclerosis: Clinical challenges and controversies, Eds.: Thompson A J, Polman C., HohJfcId R. Martin Dunitz, 1997,13−34,
- Schildcr P, Zur Kemttnis der sogenanmen diffusen sclerose (IJbcr encephalitis periaxialis diffusa).//Z.Ges Neurol. Psychiat. 1912- 10: 1−60.
- Schumacher F.A., Beeve G.W., Kiblcr R.F. et al. Problems of experimental trials of therapy in multiple sclerosis. // Ann. N. Y, Acad. Sci, 1965- 122- 552 568,
- Sindick C.J.M., Latcrrc E, C. Oligi>clonal free к and к bands in the CSF of patients with MS and other neurological diseases, An immunoaffinity-mediated capillary blot study, ti J. Neuroimmunol, 1991- 33 (1): 63−72.
- Siva A. Kantarci O. An introduction to the clinical spectrum of inflammatory demycl mating disorders of the central nervous system. Ц In: Cook S. (Ed.), Handbook of multiple sclerosis. New York, 2001- 449−462.
- Smith K. Kapoor R., Hall S" Devies M, Electrically active axons degenerate when exposed to nitric ox id. Ann. Neurol, 2001- 49: 470−476.
- Soldan S. S, Berti R., Salem N. et al. Association of human herpes virus 6 (HHV6) with muliiple sclerosis- increased JgM responce to HHV6 early antigen and detection of serum HHV6 DNA. // Nat. Med. 1997- 3: 1394−1397.
- Sommer N., Martin R, The role of T-cells and cytokines in the pathogenesis of multiple sclerosis, // In- «Multiple Sclerosis: Clinical Challenges and Controversies» Eds.: A J, Thompson, C. Polman, R, Hohlfeld- Martin Dunitz, 1997,350P, 87−108,
- Spickctt G, Oxford handbook of Clinical Immunology. Oxford University Press, 1999, 715 P.
- Thompson A J, Differences between primary and secondary progressive multiple sclerosis. // In: Frontiers in Multiple Sclerosis, V, 2, Eds.: Siva A. Kesselring J. Thompson AJ. Martin Dunilz, 1999, 29−36,
- Thompson EJ. Do we have reliable biochemical markers for the disease dynamic of multiple sclerosis? // Clin. Chem. and Lab. Med, 2001- 39 (S). S99.
- Thompson E.J. The use and significance of oligoclonal bands in multiple sclerosis, // In: Rose F, C" Jones R., ed (s). Multiple sclerosis: Immunological, Diagnostic and Therapeutic Aspects. London: John Libbey &. Co., 1987: III-114.
- Thorpe J" Mumford C., Compslon D. et al, British Isles survey of multiple sclcrosis in twins: MRI, f! J, Neurol,. Neurosurg., Psychiatry 1994- 57. 491 496.
- Thorpe J.W., Kidd D" Miller D H, et al. Spinal cord MRI using multi-array coils and fast spin-echo. I. Findings in normal controls. // Neurology 1993- 43: 2625−2631.
- Thorpe J.W. Kidd D" Moseley I.F. Spinal MRI in patients with suspcctcd multiple sclcrosis and negative brain MRI. // Brain 1996- 119- 709−714.
- Tibbling G., Link H., Ohman S. Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. // Scand.J.ain.Lab-Invesl-1977- 37:380−385.
- Tienari P., Saloncn 0″ Valanne J" Palo J. Familial multiple sclerosis: MRI Endings in clinically affected and unaffectcd siblings. // J. Neurol., Neurosurg., Psychiatry 1992- 55:883−886.
- Tintore M., Rovira A" Martinez M. et al. Isolated dcmyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis, // AmJ, Neuroradiol. 2000- 21: 702−706.
- Tourbah Л., S tie v en art J.L., Abanou A., Fontaine В., Cabanis E. A-, Lyon-Caen 0. Correlating multiple MRI parameters with clinical features: an attempt to define a new strategy in multiple sclerosis. // Neuroradiology 2001 — Vol, 43 -p. 712−720.
- Tyler J.L., Strolher S.C., Zatorrc RJ., Alivisatos B" Worsley К J. Diksic M. Yamamoto Y.L. Stability if regional cerebral glucose metabolism in the normal brain measured by positron emission tomography. // J Nud Med 1988 -Vol.29 -p.to 1−642,
- Vcrvlici G. Claeys H. VanHaver H et at. Interferon production and natural killer cclt (NK) activity in leukocyte cullurcs from multiple sclerosis patients. // J Neurol Sci 1983- 60:137—150.
- Visser JJ. Scholten R.J.P.M., Hocckman K. Nitric oxide synthesis in bacterial meningitis. // Ann. Intern. Med. 1994- 120:345−346.
- Weinschenkcr В., Gilbert G., Ebers J. Some clinical and pathological observation on chronic myelopathy, a variant of multiple sclerosis. // J. Neurol., Neurosurg, Psyehiairy, 1990- 53 (2) — 146−149.
- Wcinshenker B. Atypical demyelinating syndromes. // Multiple sclerosis- 2004: 10(suppl.2): S101.
- Weinshenker B. Neuromyelitis optica: what it is and what it might be. // Lancet, 2003- 361: 889−890,
- Weinshenker B.G., Milter D Multiple sclerosis: one disease or many? // In: Frontiers in Multiple Sclerosis, V.2r Eds.: Siva A., Kesselring J., Thompson A J. Martin DuniK, 1999.37−46
- Weinshenker B.G. Wingerchuk D, M" Lucchinctli C. F" Lcnnon V. A A marker autoantibody discriminates neuromyelitis optica from multiple sclerosis, H Neurology 2003- 60(suppl. I): A520.
- Whcttcn-Goldsiein K., Sloan F. A+ Goldstein L.B., Kulas E. D, A comprchencivc assessment of rive cost of mulltple sclerosis in the United Slates. И Multiple sclerosis 1998,4:419−425.
- Whitaker J" N. Bashir K-, Benvenisie E.N. Cerebrospinal fluid.// In: Cook S. (Ed.) Handbook of mull i pic sclcrosis. New York, 2001- 347−375.
- Wingerchuk D.M. Neuromyelitis optica- current concepts, // Frontiers in Bioscience 2Ш 9: 834−840,
- Wingerehuk D.M., Lucchinctti CF, Nose worthy J.H. Multiple sclerosis- current pathophysiological concepts. // Lab. Invest, 2001- 81 (3): 263−281.
- Wingerchuk D.M., Weinshenker B, G. Neuromyelitis optica. // In: McDonald W, l" Nose worthy J. H, Butterworth-Heinemann, Woburn М.Л. (Eds.) Multiple sclerosis. Elsevier Sciences (USA) 2003: 243−258,
- Wingerchuk D.M., Weinshenkci B.G. Neuromyelitis optica: Clinical predictors of a relapsing course and survival. // Neurology, 2003- 60- 848−853.
- Wink D. A-, Kaspraak K-S" Maragos C M. el al. DNA dcaminating ability and genotox icily of nitric oxide and its progenitors. H Science.- 1991 -254,-p 10 011 003.
- Wolinsky J.S. New insights in primary progressive multiple sclcrosis, H Multiple Sclerosi5.-2004.-v. 10, suppl.2, SI 10,
- Wolinsky J.S., Narayana P.A. Magnetic resonance spectroscopy in multiple sclerosis- window into the diseased brain. Current Opinion in Neurol,-2002,-15,-p247−251.
- Wood M. Anderson M. Neurological Infections. W.B. Saunders Company, 1988- 666p,
- Yamashila Т. Ando I" Obayashi K, Et al. Changes in nitrite and nitrate levels in patients with multiple sclerosis, // J. Neurol, Sci,-1997, — 153,-p32−34.
- Yao D., Webster H, D" Hudson L. et al. Concentric sclerosis (Balo): morphometric and in situ hybridization study of lesions in six patients. Ц Ann. Neurol, 1994- 35: 18−30.
- Young I., Hall A., Pullis C. el al. Nuclear magnetic resonance imaging in multiple sclerosis, ii Lancet I98L- 2.- p. 1063−1066,0 L
- Zaffaroni M" Gherai A., Bcrgamaschi R, ct al. Csf findings in 44 eases of Devices neuromyelitis optica. // Multiple sclerosis- 2003.- v.9- September, supp.2., p. l33.
- Zhao G., Li D.K.B., Cheng Y., Paly D. Possible prognostic significance of dirty appearing white matter on MR. in multiple sclerosis. И Multiple sclerosis, 2ШЗ-- v.9.- September, supp]. 2., p.26l.